Modulari-T
We teach your immune system to attack and cure cancer
Montreal, Canada
4 employees
Healthcare
Seed · $500K
About Modulari-T
We teach your immune system to attack and cure cancer
We teach your immune system to attack and cure cancer
We teach your immune system to attack and cure cancer
Total raised
$500K
Last stage
Seed
Investors
Stephanie Mok
Co-founder and COO at Modulari-T. PhD in chemical engineering. Technical background in synthetic biology, advanced 3D cell culture systems, and biomaterials in the context of the cellular cancer microenvironment. Fascinated by the innovations cell-based therapies, food products, and the scale up of their manufacturing. Gave the unconference talk "Lessons learned and mistakes made growing the world's hottest peppers".
LinkedIn
David White
David is the CEO and cofounder of Modulari-T. His expertise spans multiple areas and he is driven by a passion for pushing the boundaries of technology. During his PhD he discovered how protein receptors form complex structures that allow them to alter cells’ behavior. He then took this knowledge and the novel technology that was developed to build Modulari-T. When he’s not thinking up a new way to engineer cells he can be spotted biking or running up a mountain.
LinkedInDavid Cotnoir-White
Co-founder of Modulari-T Biosciences with expertise in cell and gene therapies, leading scientific strategy and platform innovation including the MARC platform.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
Étienne Gagnon
Co-founder and Chief Scientific Officer at Modulari-T Bio, contributing to the development of next-generation cell and gene therapies.
LinkedInIf they’re a yes, I book the chat. You show up — that’s the whole job-hunt.